News Feed
C-COM REPORTS FIRST QUARTER RESULTS
Company posts healthy Q1 results and maintains quarterly dividend payout – for 48 consecutive quarters. OTTAWA, April 17, 2024 – C-COM Satellite Systems Inc., (TSXV: CMI and OTCQB: CYSNF) a leading global provider of commercial grade […]
PTX Metals Announces Flow Through Financing to Accelerate Activities and for Phase 2 Drilling at W2
(All figures are expressed in Canadian dollars unless otherwise indicated) TORONTO, April 17, 2024 (GLOBE NEWSWIRE) — PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”) is pleased to announce that the […]
Platinex Inc. Announces Name Change to PTX Metals Inc.
TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased to announce the completion of the name change to PTX Metals Inc. effective February 28, 2024. […]
PLATINEX ANNOUNCES INCREASED FLOW THROUGH FINANCING AND RECEIPT OF STUDY RESULTS ON THE W2 COPPER-NICKEL-PGE PROJECT IN NORTHERN ONTARIO
Toronto, Ontario, December 1, 2023 – Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased to announce that the Company has increased its previously announced flow through financing (see press release dated Nov 27, 2023) to […]
PLATINEX MAKES NEW GOLD DISCOVERY AT HEENAN PROPERTY IN THE SWAYZE AREA OF THE ABITIBI GREENSTONE BELT
Toronto, Ontario, November 09, 2023 – Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased to announce results from its exploration program on the Heenan Property, part of the Heenan Mallard Gold […]
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
DENVER, Oct. 30, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of dysregulated immune responses including hyperinflammation on vital organs, announces that the U.S. […]
FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome
DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces receipt of U.S. Food and Drug Administration […]